Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Proshares Trust (ZBIO) Net Margin (2023 - 2025)

Historic Net Margin for Zenas BioPharma (ZBIO) over the last 3 years, with Q1 2025 value amounting to 335.73%.

  • Zenas BioPharma's Net Margin changed N/A to 335.73% in Q1 2025 from the same period last year, while for Sep 2025 it was 1292.19%, marking a year-over-year change of. This contributed to the annual value of 3226.94% for FY2024, which is 31526900.0% down from last year.
  • Latest data reveals that Zenas BioPharma reported Net Margin of 335.73% as of Q1 2025.
  • Zenas BioPharma's Net Margin's 5-year high stood at 71.25% during Q3 2023, with a 5-year trough of 1130.68% in Q4 2024.
  • Moreover, its 3-year median value for Net Margin was 335.73% (2025), whereas its average is 465.05%.